4 ms·

I think the issue is not with the training step but with the validation step. The only way to build enough trust is to carefully run a prospective clinical tria

I think the issue is not with the training step but with the validation step. The only way to build enough trust is to carefully run a prospective clinical trial, and before that you probably need enough retrospective evidence to get some sort of FDA approval. These processes take a lot of time and it’s not surprising that a year and a half after COVID-19 became widespread in the US, we still don’t have a fully validated model.

dontreact 5y ago
In fact the claim the paper makes is that no model has been sufficiently clinically validated. Problem is: how do you get enough buy in from clinicians to run a clinical trial with YOUR model, when there are hundreds of crappy models out there? It takes a lot of time to run these studies for this reason to start with and then depending on the size of the clinical trial, it takes time for the trial to run it’s course.